• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ALBENDAZOLE Drug Record

  • Summary
  • Interactions
  • Claims
  • ALBENDAZOLE chembl:CHEMBL1483 ApprovedAntineoplastic

    Alternate Names:

    SK&F-62979
    ESKAZOLE
    ZENTEL
    VALBAZEN
    ALBENZA
    SK&F 62979
    NSC-220008
    ZENTAL
    ALBENDAZOLE
    O-METHYL N-(5-(PROPYLTHIO)-2-BENZIMIDAZOLYL)CARBAMATE
    ALBENDAZOLUM
    5-(PROPYLTHIO)-2-CARBOMETHOXYAMINOBENZIMIDAZOLE
    ALBENDAZOL
    PROFTRIL
    RICOBENDAZOLE
    (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)CARBAMIC ACID METHYL ESTER
    RYCOBENDAZOLE
    rxcui:430
    chemidplus:54965-21-8
    pubchem.compound:2082
    chembl:CHEMBL1483
    drugbank:00518

    Drug Info:

    (0 More Sources)

    Publications:

    Yoshinari K et al., 2008, Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements., Biochem Pharmacol
    Lee CA et al., 2010, Identification of novel substrates for human cytochrome P450 2J2., Drug Metab Dispos
  • ALBENDAZOLE   CYP2J2

    Interaction Score: 2.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    19923256


    Sources:
    PharmGKB

  • ALBENDAZOLE   HSPB1

    Interaction Score: 0.33

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ALBENDAZOLE   TUBB

    Interaction Score: 0.2

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • ALBENDAZOLE   CYP1A2

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18502397


    Sources:
    DTC PharmGKB

  • ALBENDAZOLE   ATAD5

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ALBENDAZOLE   GMNN

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PharmGKB: albendazole

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Lee CA et al., 2010, Identification of novel substrates for human cytochrome P450 2J2., Drug Metab Dispos
    Yoshinari K et al., 2008, Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements., Biochem Pharmacol

  • DTC: ALBENDAZOLE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1483 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Albendazole

    • Version: 2020.06.01

    Alternate Names:
    D00KVO TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1483

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21